chalcone has been researched along with Carcinoma, Non-Small Cell Lung in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Baginski, M; Cekala, K; Dzierzynska, M; Jurasz, J; Maciejewska, N; Olszewski, M; Serocki, M; Wieczerzak, E | 1 |
| Fang, WS; Liu, J; Lv, G; Niu, S; Wang, H; Wang, N; Zhang, G | 1 |
| Akgun, O; Ari, F; Aydin, I; Coskun, D; Erturk, E; Onur, OE | 1 |
| An, Q; Jiang, M; Xu, N; Zhou, LY | 1 |
| Cao, C; Liu, X; Su, L; Xu, L; Yang, L; Zhong, D | 1 |
| Ho, WS; Zhou, Y | 1 |
| Jeong, JH; Kwon, TK; Oh, YJ; Seo, YH | 1 |
| Chen, TC; Chen, YL; Cheng, CM; Hsu, CY; Lu, YJ; Tseng, CH; Tso, HC; Tzeng, CC | 1 |
| Chiang, LC; Hsu, YL; Kuo, PL; Lin, CC | 1 |
9 other study(ies) available for chalcone and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Novel chalcone-derived pyrazoles as potential therapeutic agents for the treatment of non-small cell lung cancer.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Pyrazoles; Structure-Activity Relationship; Tubulin | 2022 |
Structure Modification of FXR Antagonistic Chalcones and Their Inhibitory Effects on NSCLC Cell Proliferation and Metastasis.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Chalcone; Chalcones; Humans; Lung Neoplasms; Receptors, Cytoplasmic and Nuclear | 2022 |
Targeting the epithelial-mesenchymal transition (EMT) pathway with combination of Wnt inhibitor and chalcone complexes in lung cancer cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Chalcone; Chalcones; Epithelial-Mesenchymal Transition; Humans; Lung; Lung Neoplasms; Niclosamide | 2023 |
Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
Topics: A549 Cells; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chalcone; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; Lipopolysaccharides; Lung Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinones; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
The chalcone 2'-hydroxy-4',5'-dimethoxychalcone activates death receptor 5 pathway and leads to apoptosis in human nonsmall cell lung cancer cells.
Topics: Activating Transcription Factor 4; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Non-Small-Cell Lung; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Cycle Checkpoints; Cell Line, Tumor; Chalcone; Chalcones; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Endoplasmic Reticulum Stress; Gene Expression; Humans; Lung Neoplasms; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; Transcription Factor CHOP; Transcriptional Activation; Up-Regulation | 2013 |
Combination of liquiritin, isoliquiritin and isoliquirigenin induce apoptotic cell death through upregulating p53 and p21 in the A549 non-small cell lung cancer cells.
Topics: Aldehyde Reductase; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Survival; Chalcone; Chalcones; Cyclin-Dependent Kinase Inhibitor p21; Enzyme Activation; Enzyme Inhibitors; Flavanones; Glucosides; Glycyrrhiza uralensis; Humans; L-Lactate Dehydrogenase; Lung Neoplasms; M Phase Cell Cycle Checkpoints; Plant Extracts; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Tumor Suppressor Protein p53 | 2014 |
Chalcone-templated Hsp90 inhibitors and their effects on gefitinib resistance in non-small cell lung cancer (NSCLC).
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Survival; Chalcone; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gefitinib; HSP90 Heat-Shock Proteins; Humans; Lung Neoplasms; Molecular Docking Simulation; Protein Structure, Secondary; Quinazolines | 2017 |
Synthesis and antiproliferative evaluation of 3-phenylquinolinylchalcone derivatives against non-small cell lung cancers and breast cancers.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chalcone; Drug Screening Assays, Antitumor; Female; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Quinolines | 2013 |
Isoliquiritigenin inhibits the proliferation and induces the apoptosis of human non-small cell lung cancer a549 cells.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; DNA Fragmentation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Fas Ligand Protein; fas Receptor; Humans; Lung Neoplasms; Membrane Glycoproteins; Oncogene Protein p21(ras); Tumor Suppressor Protein p53 | 2004 |